Adult celiac disease;Enfermedad celíaca del adulto

Revista Medica de Chile

Volumn 135, Issue 9, 2007, Pages 1186-1194

  Heredia P, Carolina ^a   Castro P, Fabiola ^a   Palma H, Joaquín ^a  

^a HOSPITAL DEL SALVADOR   (Chile)

Author keywords

Celiac disease; Gliadin; Gluten; Steatorrhea

Indexed keywords

GLUTEN; HLA ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; CELIAC DISEASE; DIET THERAPY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; MALE; PATHOLOGY; REVIEW; SEROLOGY;

ADULT; CELIAC DISEASE; FEMALE; GLUTEN; HLA ANTIGENS; HUMANS; INTESTINAL MUCOSA; MALE; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; TRANSGLUTAMINASES;

EID: 36348961271     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. ELSON CH, BALLEW M, BARNARD J, BERNSTEIN S, CHECK I, COHEN M ET AL. National Institutes of Health Consensus Development. Conference Statement on Celiac Disease, June 28-30, 2004. Gastroenterology 2005; 128: S1-S9.
2. REWERS M, LIU E, SIMMONS J, REDONDO M, HOFFENBERG E. Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin N Am 2004; 33: 197-214.
3. SHAMIR R. Advances in celiac disease. Gastroenterol Clin N Am 2003; 32: 931-47.
4. FASANO A, CATASSI C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636-51.
5. NOT T, HORVATH K, HILL ID. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998; 33: 494-8.
6. HOVDENAK N, HOVLID E, AKSNES L. High prevalence of asymptomatic celiac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol 1999; 11: 185-
7. GANDOLFI L, PRATESI R, CORDOBA JC. Prevalence of celiac disease in healthy blood donors in Brazil. Am J Gastroenterol 2000; 95: 689-92.
8. TREVISIOL C, NOT T, BERTY I. Screening of celiac disease in healthy blood donors at two immunotransfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 1999; 31: 584-6.
9. REWERS M. Epidemiology of Celiac Disease: What are the prevalence, incidente, and progression of Celiac Disease? Gastroenterology 2005; 128: S47-S51.
10. NELSEN D. Gluten-Sensitive Enteropathy (Celiac Disease): More common than you think. Am Fam Physician 2002: 66: 2259-66, 2269-70.
11. AMERICAN GASTROENTEROLOGICAL ASSOCIATION. AGA Technical Review on Celiac Disease. Gastroenterology 2001; 120: 1526-40.
12. KAGNOFF M. Overview and Pathogenesis of Celiac Disease. Gastroenterology 2005; 128: S10-S18.
13. DEJAR D, CICLITIRA P. Clinical Features and Diagnosis of Celiac Disease. Gastroenterology 2005; 128: S19-S24.
14. GREEN P. The Many Faces of Celiac Disease: Clinical Presentation of Celiac Disease in the Adult Population. Gastroenterology 2005; 128: S74-S78.
15. MURRIA J. Celiac Disease in Patients with an Affected Member, Type 1 Diabetes, Iron Deficiency, or Osteoporosis? Gastroenterology 2005; 128: S52-S56.
16. FINE K. The prevalence of occult gastrointestinal bleeding in Celiac Sprue. N Engl J Med 1996; 334: 1163-7.
17. BUSHARA K. Neurologic Presentation of Celiac Disease. Gastroenterology 2005; 128: S92-S97.
18. ZONE J. Skin Manifestations of Celiac Disease. Gastroenterology 2005; 128: S87-S91.
19. SMYTH C, KELLEHER K, KEELING P. Hepatic manifestations of gastrointestinal diseases: Inflammatory bowel disease, celiac disease, and Whipple's disease. Clin Liver Dis 2002; 6: 1013-32.
20. FARRELL R, KELLY C. Diagnosis of celiac sprue. Am J Gastroenterol 2001; 96: 3237-4.
21. MARSH MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiological approach to the spectrum of gluten sensitivity. Gastroenterology 1992; 102: 330-54.
22. RIBES M, FOTOULAKI L, BLESA P, AUGOUSTIDOU-SAVOPOULOU M, HERNÁNDEZ F, KANAKOUDI-TSAKALIDES A ET AL. Celiac disease diagnosis: Similar high sensitivity for IgA-AGA using a home-made ELISA method in 2 European Pediatric Gastroenterology Units (PGU'S). Gut 1997; 41 (Suppl 3).
23. KILANDER AF, NILSSON LA, GILLBERG R. Serum antibodies to gliadin in celiac disease after gluten withdrawal. Scand J Gastroenterol 1987; 22: 29.
24. UIBO O, UIBO R, KLEIMOLA V. Serum IgA anti-gliadin antibodies in an adult population sample. High prevalence without celiac disease. Dig Dis Sci 1993; 38: 2034.
25. GRODZINSKY E, HED J, LIEDEN G. Presence of IgA and IgG antigliadin antibodies in healthy adults as measured by micro-ELISA. Effect of various cutoff levels on specificity and sensitivity when diagnosing celiac disease. Int Arch Allergy Appl Immunol 1990; 92: 119.
26. HED J, LIEDEN G, OTTOSSON E. IgA anti-gliadin antibodies and jejunal mucosal lesions in healthy blood donors (letter). Lancet 1986; 2: 215.
27. DIETERICH W, EHNIS T, BAUER M. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
28. HILL H. What Are the Sensitivity and Specificity of Serologic Tests for Celiac Disease? Do Sensitivity and Specificity Vary in Different Populations? Gastroenterology 2005; 128: S25-S32.
29. VENTURA A, MAGAZZU G, GRECO L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297.
30. CORRAO G, CORAZZA GR, BAGNARDI V. Mortality in patients with celiac disease and their relatives: A cohort study. Lancet 2001; 358: 356.
31. HOLMES GK, PRIOR P, LANE MR. Malignancy in celiac disease: Effect of a gluten free diet. Gut 1989; 30: 333.
32. ASKLING J, LINET M, GRIDLEY G. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123: 1428.
33. COLLIN P, REUNALA T, PUKKALA E. Celiac disease - associated disorders and survival. Gut 1994; 35: 1215.
34. JANATUINEN EK, KEMPPAINEN TA, JULKUNEN RJ, KOSMA VM, MÄKI M, HEIKKINEN M ET AL. No harm from five-year ingestion of oats in celiac disease. Gut 2002; 50: 332.
35. SCHMITZ J. Lack of oats toxicity in celiac disease: Toxic fraction makes up less of total protein than in other cereals (editorial). BMJ 1997; 314: 159.
36. PERAAHO M, KAUKINEN K, MUSTALAHTI K. Effect of an oats containing gluten-free diet on symptoms and quality of life in celiac disease: a randomized study. Scand J Gastroenterol 2004; 39: 27-31.
37. STORSRUD S, OLSSON M. Adult celiac patients do tolerate large amounts of oats. Eur J Clin Nutr 2003; 57: 163-9.
38. MCKINLEY M, LEIBOWITZ S, BRONZO R. Appropriate response to pneumococcal vaccine in celiac sprue. J Clin Gastroenterol 1995; 20: 113.
39. LEE SK, LO W, MEMEO L. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003; 57: 187.
40. SELBY WS, PAINTER D, COLLINS A. Persistent mucosal abnormalities in celiac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol 1999; 34: 909.
41. TRIER J, FALCHUK Z, CAREY M, SCHREIBER D. Celiac sprue and refractory sprue. Gastroenterology 1978; 75: 307-16.
42. TRIER J. Celiac sprue. N Engl J Med 1991; 325: 1709-19.
43. BARRY R, READ A. Celiac disease and malignancy. QJM 1973; 42: 665-73.
44. HAMILTON J, CHAMBERS R, WYNN-WILLIAMS A. Role of gluten, prednisone and azathioprine in non-responsive celiac disease. Lancet 1976; 1: 1213-16.
45. ROLNY P, SIGURJONSOTTIR HA, REMOTTI H. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999; 94: 219.
46. VAIDYA A, BOLANOS J, BERKELHAMMER C. Azathioprine in refractory sprue. Am J Gastroenterol 1999; 94: 1967.
47. MAURINO E, NIVELONI S, CHERNAVSKY A. Azathioprine in refractory sprue: Results from a prospective, open-label study. Am J Gastroenterol 2002; 97: 2595.
48. LONGSTRETH GF. Successful treatment of refractory sprue with cyclosporine. Ann Intern Med 1993; 119: 1014.
49. GILLETT H, ARNOTT I, MC INTYRE M, CAMPBELL S, DAHELE A, PRIEST M ET AL. Successful Inßiximab Treatment for Steroid-Refractory Celiac Disease: A Case Report. Gastroenterology 2002; 122: 800-5.
50. HOLMES GKT, STOKES PL, SORAHAN TM, PRIOR P, WATERHOUSE JAH, COOKE WT. Celiac disease, gluten-free diet and malignancy. Gut 1976; 17: 612-19.
51. HOWDLE PD, JALAL PK, HOLMES GKT, HOULSTON RS. Primary smallbowel malignancy in the UK and its association with celiac disease. Q J Med 2003; 96: 345-53.
52. GREEN PH, FLEISCHAUER AT, BHAGAT G. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115: 191.
53. ASKLING J, LINET M, GRIDLEY G, HALSTENSEN TS, EKSTROM K, EKBOM A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123: 1428-35.
54. FARRÉ C, DOMINGO-DOMENECH E, FONT R, MARQUES T, DE SEVILLA AF, ALVARO T ET AL. Celiac disease and lymphoma risk: a multicentre case-control study in Spain. Dig Dis Sci 2004; 49: 408-12.
55. FREEMAN HJ. Lymphoproliferative and intestinal malignancies in 214 patients with biopsy-defined celiac disease. J Clin Gastroenterol 2004; 38: 429-34.
56. CARD TR, WEST J, HOLMES GKT. Risk of malignancy in diagnosed celiac disease: a 24-year prospective, population-based cohort study. Aliment Pharmacol Ther 2004; 20: 769-75.
57. WEST J, LOGAN RFA, HILL PG, LLOYD A, LEWIS S, HUBBARD R ET AL. Seroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut 2003; 52: 960-5.
58. SNOOK JA, DWYER L, LEE-ELLIOTT C, KHAN S, WHEELER DW, NICHOLAS DS. Adult celiac disease and cigarette smoking. Gut 1996; 39: 60-2.